ABCC6P1: A Potential Drug Target and Biomarker for ABC Transporter-Mediated Transport

Target Name: ABCC6P1

NCBI ID: G653190

ABCC6P1

Other Name(s): ATP binding cassette subfamily C member 6 pseudogene 1

ABCC6P1: A Potential Drug Target and Biomarker for ABC Transporter-Mediated Transport

ABCC6P1 (ATP binding cassette subfamily C member 6 pseudogene 1) is a gene that encodes a protein involved in the intracellular transport of various molecules, including drugs, ions, and small molecules. The ABCC6P1 gene is a member of the ABCC6P1 gene family, which is known to encode a family of transporters that play a crucial role in regulating the transport of various molecules across cell membranes. The ABCC6P1 gene has been identified as a potential drug target and biomarker due to its involvement in drug transport and its expression patterns in various diseases, including cancer.

Understanding the Function of ABCC6P1

ABCC6P1 is a 21-kDa protein that belongs to the subfamily C of the ATP binding cassette (ABC) transporter family. The ABC transporter family is a large family of transmembrane proteins that play a crucial role in regulating the transport of various molecules across cell membranes, including drugs, ions, and small molecules. The ABCC6P1 gene encodes a protein that is similar in structure and function to other members of the ABCC6P1 gene family.

The ABCC6P1 protein is involved in the transport of various molecules across the cell membrane, including drugs that are commonly used in cancer treatment, such as taxanes and vinca alkaloids. These drugs work by inhibiting the activity of tubulin, which is a key component of microtubules that play a crucial role in cell division and transport of molecules across the cell membrane. By inhibiting tubulin activity, the drugs can inhibit cell division and kill cancer cells.

In addition to its role in drug transport, ABCC6P1 is also involved in the regulation of ion and small molecule transport in various physiological processes, including cell signaling, cell adhesion, and intracellular signaling.

Potential Drug Target

The ABCC6P1 gene has been identified as a potential drug target due to its involvement in drug transport and its expression patterns in various diseases, including cancer. ABCC6P1 has been shown to be involved in the transport of taxanes, which are commonly used in cancer treatment, such as taxanes and vinca alkaloids.

In addition to its role in cancer treatment, ABCC6P1 has also been shown to be involved in the transport of other molecules that are commonly used in therapeutic applications, including anti-inflammatory drugs, anesthetics, and psychedelics.

Biomarker Potential

ABCC6P1 has also been identified as a potential biomarker for various diseases, including cancer. The expression patterns of ABCC6P1 have been shown to be altered in various diseases, including cancer, which suggests that ABCC6P1 may be a useful biomarker for cancer diagnosis and treatment.

Expression of ABCC6P1 has been shown to be increased in various types of cancer, including breast, ovarian, and colorectal cancers. In addition,ABCC6P1 has also been shown to be involved in the regulation of cellular signaling pathways, which are often disrupted in cancer cells.

Conclusion

In conclusion, ABCC6P1 is a gene that encodes a protein involved in the intracellular transport of various molecules, including drugs, ions, and small molecules. The ABCC6P1 gene has been identified as a potential drug target and biomarker due to its involvement in drug transport and its expression patterns in various diseases, including cancer. Further research is needed to fully understand the function of ABCC6P1 and its potential as a drug target and biomarker.

Protein Name: ATP Binding Cassette Subfamily C Member 6 Pseudogene 1

The "ABCC6P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ABCC6P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets